HALO
#982
Halozyme Therapeutics, Inc. - Common Stock
75.0 5 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.39%
Variación mensual
+4.80%
Variación en los últimos 6 meses
+4.77%
Cambio anual
+12.35%
Cierres anteriores
76.1 1
Open
75.0 5
Mínimo
75.0 5
High
75.0 5
Volumen
231
Financials
- Market Capitalization 8.9 B
- Employee 423
- Founded 1998
- CEO Helen I. Torley
- Website www.halozyme.com
- Headquarter Delaware, United States
- FIGI BBG000CZ8W54
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
26.29
Relación precio/flujo de caja
5.97
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 959 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 327.68 USD | +4.17% | +1.30% | +23.69% | +529.19% | 9.14 B USD | ||
| 966 |  IONS Ionis Pharmaceuticals, Inc. - Common Stock | 54.93 USD | -3.21% | -35.80% | -25.70% | -23.84% | 9.08 B USD | ||
| 988 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.71 USD | +0.05% | +0.19% | +137.41% | +103.67% | 8.83 B USD | ||
| 999 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 98.95 USD | +5.57% | +4.89% | +18.45% | +313.84% | 8.59 B USD |